EPISODE · Feb 25, 2026 · 3 MIN
글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026
from Citeline Podcasts · host Norstella
특허 만료와 미국 내 약가 압박은 대형 글로벌 제약사들이 극복해야 할 과제이며, 다수 제약사가 올해 소폭의 실적 상승을 전망하고 있다는 Scrip 기사를 요약한 내용입니다. https://insights.citeline.com/scrip/drug-pricing/drug-makers-confront-headwinds-in-2026-but-mfn-doesnt-seem-like-a-big-one-YYQBO72NSNCHBE6EBPKF2GSDB4/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Embed this episode
Ready to play
글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026
0:00
3:44
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 3 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on February 25, 2026.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!